在急性髓性白血病中,DNA甲基化和缺氧之间的交叉关系
Sam Humphries1,2, Danielle R Bond1,2, Zacary P Germon1,2
1School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, 2308, Australia.
Clinical epigenetics
|September 13, 2023
概括
在急性髓性白血病 (AML) 中,DNA甲基化和缺氧是关键驱动因素. 缺氧可能会限制低甲基化剂的疗效,这表明需要新的联合治疗来改善AML患者的治疗结果.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 血液学 血液学 血液学
背景情况:
- 急性髓性白血病 (AML) 是由不受控制的髓性细胞增殖驱动的.
- 表观遗传变化,特别是DNA甲基化变化,在AML病变发生过程中至关重要.
- 骨髓微环境,以缺氧为特征,有助于白血病发生.
研究的目的:
- 审查在AML中DNA甲基化和缺氧骨髓微环境之间的相互作用.
- 阐明缺氧如何影响DNA甲基化信号通路.
- 讨论这些相互作用对AML治疗的临床影响.
主要方法:
- 审查关于DNA甲基化,缺氧和AML的现有文献.
- 分析受低氧影响的信号通路.
- 检查缺氧对表观遗传调节剂及其活性的影响.
主要成果:
- 缺氧通过代谢途径影响DNA甲基化,对表观遗传调节者的转录控制,以及直接的酶作用.
- 存在双向交叉声,其中DNA甲基化可以影响低氧反应基因.
- 缺氧骨髓中细胞循环减少可能会降低低甲基化剂的有效性.
结论:
- 缺氧和DNA甲基化相互作用显著影响AML的进展.
- 低甲基化剂的有效性可能会在缺氧骨髓利基中受到损害.
- 未来的AML疗法应该探索共同治疗,以提高低甲基化剂的有效性,可能通过促进AML细胞循环或与骨髓脱离.
更多相关视频
13:47Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
25.6K
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
8.3K
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
Histone Modification
13.4K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.4K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
